Transcranial magnetic stimulation (TMS) measured cortical inhibition provides insight into interindividual differences in progressive myoclonic epilepsy. In patients with progressive myoclonic epilepsy type 1 (EPM1), abnormality of intracortical inhibition measured by transcranial magnetic stimulation (TMS) is associated with the magnitude of the genetic change, a new study shows. According to the researchers, TMS could prove […]
Read More… from TMS study could be helpful for epilepsy prognosis